+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Natural Killer Cell Therapeutics Market by Type (Allogeneic, Autologous), Indication (Autoimmune Disease, Hematological Malignancies, Infectious Disease), Source, End User - Global Forecast 2025-2030- Product Image
Natural Killer Cell Therapeutics Market by Type (Allogeneic, Autologous), Indication (Autoimmune Disease, Hematological Malignancies, Infectious Disease), Source, End User - Global Forecast 2025-2030- Product Image
Sale

Natural Killer Cell Therapeutics Market by Type (Allogeneic, Autologous), Indication (Autoimmune Disease, Hematological Malignancies, Infectious Disease), Source, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 191 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5925190
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The natural killer cell therapeutics market is entering a phase of rapid scientific and commercial advancement, with new cellular engineering and immuno-oncology strategies accelerating the development of next-generation therapies. As innovation converges with evolving regulatory and manufacturing landscapes, decision-makers require nuanced analysis to align strategy, investments, and execution in this transforming sector.

Market Snapshot: Natural Killer Cell Therapeutics Market Size and Trends

The Natural Killer Cell Therapeutics Market grew from USD 6.02 billion in 2024 to USD 6.74 billion in 2025. It is expected to continue growing at a CAGR of 11.74%, reaching USD 11.72 billion by 2030. The market is benefiting from powerful drivers, including breakthroughs in cellular engineering, regulatory acceleration, and increased investment in immuno-oncology solutions for both hematological and solid tumor indications. Advancements in gene editing and scalable manufacturing platforms are enabling greater clinical reach and operational efficiency, while competitive differentiation is defined by innovative pipelines and collaborative partnerships.

Scope & Segmentation

  • Therapeutic Types: Allogeneic, including Off The Shelf and Universal Donor therapies, as well as Autologous platforms with Personalized Therapy options.
  • Indications: Covering Autoimmune Disease, Hematological Malignancies (Leukemia, Lymphoma, Multiple Myeloma), Infectious Disease, and Solid Tumors (such as Breast Cancer, Lung Cancer, and Ovarian Cancer).
  • Source Origins: Cell Line sources such as KHYG-1 and NK-92, Induced Pluripotent Stem Cells, Peripheral Blood, Umbilical Cord Blood.
  • End Users: Contract Research Organizations, Hospitals and Clinics (Academic and Research Hospitals, Cancer Centers), Research Organizations.
  • Regional Markets: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, and others), Asia-Pacific (China, India, Japan, Australia, South Korea, and more).
  • Leading Companies: Fate Therapeutics, Nkarta Therapeutics, Allogene Therapeutics, Bristol-Myers Squibb, Gamida Cell, Takeda, Kyowa Kirin, Innate Pharma, Artiva Biotherapeutics, Kiadis Pharma.

Key Takeaways: Strategic Insights for Senior Decision-Makers

  • Innovative engineered platforms are redefining the value proposition of natural killer cell therapeutics, with off-the-shelf constructs streamlining costs and timelines.
  • Personalized autologous therapies strengthen competitive advantage in precision medicine, providing targeted safety and efficacy in early development stages.
  • Stakeholder collaboration—among academic centers, biotech firms, and contract research organizations—is catalyzing discovery, validation, and commercial development.
  • Regulatory shifts, including accelerated approval pathways and real-world evidence integration, are optimizing the route from research to patient access.
  • Source diversity impacts scalability and consistency, prompting broader adoption of advanced biomanufacturing and gene editing technologies.
  • Regional differences in regulatory environments and healthcare infrastructure necessitate tailored go-to-market, partnership, and investment approaches.

Tariff Impact: Navigating Upcoming U.S. Trade Headwinds

Scheduled U.S. trade tariffs in 2025 are set to raise costs for NK cell therapeutic manufacturers by increasing prices of raw materials and critical equipment. Mid-sized and emerging innovators may be particularly challenged, as higher import duties strain research budgets, clinical trial timelines, and inventory strategies. To offset these delays, companies can leverage long-term supply contracts, onshore production partnerships, and seek tariff exclusions with assistance from regulatory experts. Aligning procurement and supply chain management with these evolving economic realities is essential to maintain momentum in innovation and patient accessibility.

Methodology & Data Sources

This market intelligence is grounded in a multi-layered research approach. Secondary analysis involved systematic review of scientific literature, clinical trial registries, corporate filings, and regulatory documents. Primary insights were gathered through interviews with industry executives, scientific leaders, and procurement specialists. Quantitative findings were triangulated across independent data sources, with validation through expert peer review and cross-referencing to ensure integrity and actionable value.

Why This Report Matters

  • Enables executive teams to benchmark strategic investments, operational models, and pipeline advancements against the evolving landscape of natural killer cell therapeutics.
  • Equip decision-makers with regional, clinical, and commercial intelligence to inform M&A, licensing, and expansion strategies within the cell therapy domain.
  • Drives confident, informed decisions by mapping regulatory, technological, and economic variables crucial for long-term market participation and sustainable growth.

Conclusion

Senior leadership will find this analysis essential for understanding key market forces and competitive positioning in natural killer cell therapeutics. Aligning strategy to scientific, regional, and operational shifts is paramount for sustainable success in this evolving sector.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of CRISPR gene editing to enhance NK cell cytotoxicity against resistant tumor phenotypes
5.2. Development of off-the-shelf allogeneic NK cell therapies to reduce production cost and improve scalability
5.3. Application of CAR-engineering to NK cells for targeting heterogeneous antigen expression in solid tumors
5.4. Emergence of IL-15 superagonist formulations to sustain in vivo NK cell proliferation and anti-tumor efficacy
5.5. Implementation of biomaterial-based NK cell delivery systems for enhanced tumor infiltration and retention
5.6. Exploration of combined checkpoint inhibition and NK cell therapy for overcoming tumor microenvironment suppression
5.7. Use of multi-omics profiling to identify predictive biomarkers for patient response to NK cell treatments
5.8. Advancement of artificial intelligence algorithms to optimize NK cell manufacturing and process control parameters
5.9. Clinical evaluation of memory-like NK cells for durable response in hematological malignancies and refractory cancers
5.10. Trials investigating NK cell combination with antibody-drug conjugates to potentiate tumor targeting and lysis
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Natural Killer Cell Therapeutics Market, by Type
8.1. Introduction
8.2. Allogeneic
8.2.1. Off The Shelf
8.2.2. Universal Donor
8.3. Autologous
8.3.1. Personalized Therapy
9. Natural Killer Cell Therapeutics Market, by Indication
9.1. Introduction
9.2. Autoimmune Disease
9.3. Hematological Malignancies
9.3.1. Leukemia
9.3.2. Lymphoma
9.3.3. Multiple Myeloma
9.4. Infectious Disease
9.5. Solid Tumors
9.5.1. Breast Cancer
9.5.2. Lung Cancer
9.5.3. Ovarian Cancer
10. Natural Killer Cell Therapeutics Market, by Source
10.1. Introduction
10.2. Cell Line
10.2.1. KHYG-1
10.2.2. NK-92
10.3. Induced Pluripotent Stem Cells
10.4. Peripheral Blood
10.5. Umbilical Cord Blood
11. Natural Killer Cell Therapeutics Market, by End User
11.1. Introduction
11.2. Contract Research Organizations
11.3. Hospitals And Clinics
11.3.1. Academic And Research Hospitals
11.3.2. Cancer Centers
11.4. Research Organizations
12. Americas Natural Killer Cell Therapeutics Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Natural Killer Cell Therapeutics Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Natural Killer Cell Therapeutics Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Fate Therapeutics, Inc.
15.3.2. Nkarta Therapeutics, Inc.
15.3.3. Allogene Therapeutics, Inc.
15.3.4. Bristol-Myers Squibb Company
15.3.5. Gamida Cell Ltd.
15.3.6. Takeda Pharmaceutical Company Limited
15.3.7. Kyowa Kirin Co., Ltd.
15.3.8. Innate Pharma S.A.
15.3.9. Artiva Biotherapeutics, Inc.
15.3.10. Kiadis Pharma N.V.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. NATURAL KILLER CELL THERAPEUTICS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY SOURCE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. NATURAL KILLER CELL THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. NATURAL KILLER CELL THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. NATURAL KILLER CELL THERAPEUTICS MARKET: RESEARCHAI
FIGURE 24. NATURAL KILLER CELL THERAPEUTICS MARKET: RESEARCHSTATISTICS
FIGURE 25. NATURAL KILLER CELL THERAPEUTICS MARKET: RESEARCHCONTACTS
FIGURE 26. NATURAL KILLER CELL THERAPEUTICS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. NATURAL KILLER CELL THERAPEUTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY ALLOGENEIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY ALLOGENEIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY OFF THE SHELF, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY OFF THE SHELF, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY UNIVERSAL DONOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY UNIVERSAL DONOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY ALLOGENEIC, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY ALLOGENEIC, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY AUTOLOGOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY AUTOLOGOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY PERSONALIZED THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY PERSONALIZED THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY AUTOLOGOUS, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY AUTOLOGOUS, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY AUTOIMMUNE DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY AUTOIMMUNE DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY LEUKEMIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY LEUKEMIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY LYMPHOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY LYMPHOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY MULTIPLE MYELOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY MULTIPLE MYELOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY SOLID TUMORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY SOLID TUMORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY BREAST CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY LUNG CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY OVARIAN CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY OVARIAN CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY SOLID TUMORS, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY SOLID TUMORS, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY CELL LINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY CELL LINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY KHYG-1, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY KHYG-1, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY NK-92, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY NK-92, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY CELL LINE, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY CELL LINE, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY PERIPHERAL BLOOD, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY PERIPHERAL BLOOD, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY UMBILICAL CORD BLOOD, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY UMBILICAL CORD BLOOD, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY ACADEMIC AND RESEARCH HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY ACADEMIC AND RESEARCH HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY CANCER CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY CANCER CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY HOSPITALS AND CLINICS, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY ALLOGENEIC, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY ALLOGENEIC, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY AUTOLOGOUS, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY AUTOLOGOUS, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY SOLID TUMORS, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY SOLID TUMORS, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY CELL LINE, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY CELL LINE, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY HOSPITALS AND CLINICS, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY ALLOGENEIC, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY ALLOGENEIC, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY AUTOLOGOUS, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY AUTOLOGOUS, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY SOLID TUMORS, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY SOLID TUMORS, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY CELL LINE, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY CELL LINE, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY HOSPITALS AND CLINICS, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 125. CANADA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 126. CANADA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 127. CANADA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY ALLOGENEIC, 2018-2024 (USD MILLION)
TABLE 128. CANADA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY ALLOGENEIC, 2025-2030 (USD MILLION)
TABLE 129. CANADA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY AUTOLOGOUS, 2018-2024 (USD MILLION)
TABLE 130. CANADA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY AUTOLOGOUS, 2025-2030 (USD MILLION)
TABLE 131. CANADA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 132. CANADA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 133. CANADA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2018-2024 (USD MILLION)
TABLE 134. CANADA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2025-2030 (USD MILLION)
TABLE 135. CANADA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY SOLID TUMORS, 2018-2024 (USD MILLION)
TABLE 136. CANADA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY SOLID TUMORS, 2025-2030 (USD MILLION)
TABLE 137. CANADA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 138. CANADA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 139. CANADA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY CELL LINE, 2018-2024 (USD MILLION)
TABLE 140. CANADA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY CELL LINE, 2025-2030 (USD MILLION)
TABLE 141. CANADA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 142. CANADA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 143. CANADA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2024 (USD MILLION)
TABLE 144. CANADA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY HOSPITALS AND CLINICS, 2025-2030 (USD MILLION)
TABLE 145. MEXICO NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 146. MEXICO NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 147. MEXICO NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY ALLOGENEIC, 2018-2024 (USD MILLION)
TABLE 148. MEXICO NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY ALLOGENEIC, 2025-2030 (USD MILLION)
TABLE 149. MEXICO NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY AUTOLOGOUS, 2018-2024 (USD MILLION)
TABLE 150. MEXICO NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY AUTOLOGOUS, 2025-2030 (USD MILLION)
TABLE 151. MEXICO NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 152. MEXICO NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 153. MEXICO NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2018-2024 (USD MILLION)
TABLE 154. MEXICO NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2025-2030 (USD MILLION)
TABLE 155. MEXICO NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY SOLID TUMORS, 2018-2024 (USD MILLION)
TABLE 156. MEXICO NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY SOLID TUMORS, 2025-2030 (USD MILLION)
TABLE 157. MEXICO NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 158. MEXICO NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 159. MEXICO NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY CELL LINE, 2018-2024 (USD MILLION)
TABLE 160. MEXICO NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY CELL LINE, 2025-2030 (USD MILLION)
TABLE 161. MEXICO NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 162. MEXICO NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 163. MEXICO NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2024 (USD MILLION)
TABLE 164. MEXICO NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY HOSPITALS AND CLINICS, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY ALLOGENEIC, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY ALLOGENEIC, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY AUTOLOGOUS, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY AUTOLOGOUS, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY SOLID TUMORS, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY SOLID TUMORS, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY CELL LINE, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY CELL LINE, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY HOSPITALS AND CLINICS, 2025-2030 (USD MILLION)
TABLE 185. ARGENTINA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 186. ARGENTINA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 187. ARGENTINA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY ALLOGENEIC, 2018-2024 (USD MILLION)
TABLE 188. ARGENTINA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY ALLOGENEIC, 2025-2030 (USD MILLION)
TABLE 189. ARGENTINA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY AUTOLOGOUS, 2018-2024 (USD MILLION)
TABLE 190. ARGENTINA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY AUTOLOGOUS, 2025-2030 (USD MILLION)
TABLE 191. ARGENTINA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 192. ARGENTINA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 193. ARGENTINA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2018-2024 (USD MILLION)
TABLE 194. ARGENTINA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY SOLID TUMORS, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY SOLID TUMORS, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY CELL LINE, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY CELL LINE, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 203. ARGENTINA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2024 (USD MILLION)
TABLE 204. ARGENTINA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY HOSPITALS AND CLINICS, 2025-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY ALLOGENEIC, 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY ALLOGENEIC, 2025-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY AUTOLOGOUS, 2018-2024 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY AUTOLOGOUS, 2025-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2018-2024 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY SOLID TUMORS, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY SOLID TUMORS, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY CELL LINE, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY CELL LINE, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY HOSPITALS AND CLINICS, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 227. UNITED KINGDOM NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 228. UNITED KINGDOM NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY ALLOGENEIC, 2018-2024 (USD MILLION)
TABLE 230. UNITED KINGDOM NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY ALLOGENEIC, 2025-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY AUTOLOGOUS, 2018-2024 (USD MILLION)
TABLE 232. UNITED KINGDOM NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY AUTOLOGOUS, 2025-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 234. UNITED KINGDOM NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2018-2024 (USD MILLION)
TABLE 236. UNITED KINGDOM NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2025-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY SOLID TUMORS, 2018-2024 (USD MILLION)
TABLE 238. UNITED KINGDOM NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY SOLID TUMORS, 2025-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 240. UNITED KINGDOM NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY CELL LINE, 2018-2024 (USD MILLION)
TABLE 242. UNITED KINGDOM NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY CELL LINE, 2025-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 244. UNITED KINGDOM NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 245. UNITED KINGDOM NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2024 (USD MILLION)
TABLE 246. UNITED KINGDOM NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY HOSPITALS AND CLINICS, 2025-2030 (USD MILLION)
TABLE 247. GERMANY NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 248. GERMANY NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 249. GERMANY NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY ALLOGENEIC, 2018-2024 (USD MILLION)
TABLE 250. GERMANY NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY ALLOGENEIC, 2025-2030 (USD MILLION)
TABLE 251. GERMANY NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY AUTOLOGOUS, 2018-2024 (USD MILLION)
TABLE 252. GERMANY NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY AUTOLOGOUS, 2025-2030 (USD MILLION)
TABLE 253. GERMANY NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 254. GERMANY NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 255. GERMANY NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2018-2024 (USD MILLION)
TABLE 256. GERMANY NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2025-2030 (USD MILLION)
TABLE 257. GERMANY NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY SOLID TUMORS, 2018-2024 (USD MILLION)
TABLE 258. GERMANY NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY SOLID TUMORS, 2025-2030 (USD MILLION)
TABLE 259. GERMANY NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 260. GERMANY NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 261. GERMANY NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY CELL LINE, 2018-2024 (USD MILLION)
TABLE 262. GERMANY NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY CELL LINE, 2025-2030 (USD MILLION)
TABLE 263. GERMANY NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 264. GERMANY NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 265. GERMANY NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2024 (USD MILLION)
TABLE 266. GERMANY NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY HOSPITALS AND CLINICS, 2025-2030 (USD MILLION)
TABLE 267. FRANCE NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 268. FRANCE NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 269. FRANCE NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY ALLOGENEIC, 2018-2024 (USD MILLION)
TABLE 270. FRANCE NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY ALLOGENEIC, 2025-2030 (USD MILLION)
TABLE 271. FRANCE NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY AUTOLOGOUS, 2018-2024 (USD MILLION)
TABLE 272. FRANCE NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY AUTOLOGOUS, 2025-2030 (USD MILLION)
TABLE 273. FRANCE NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 274. FRANCE NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 275. FRANCE NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2018-2024 (USD MILLION)
TABLE 276. FRANCE NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2025-2030 (USD MILLION)
TABLE 277. FRANCE NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY SOLID TUMORS, 2018-2024 (USD MILLION)
TABLE 278. FRANCE NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY SOLID TUMORS, 2025-2030 (USD MILLION)
TABLE 279. FRANCE NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 280. FRANCE NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 281. FRANCE NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY CELL LINE, 2018-2024 (USD MILLION)
TABLE 282. FRANCE NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY CELL LINE, 2025-2030 (USD MILLION)
TABLE 283. FRANCE NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 284. FRANCE NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 285. FRANCE NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2024 (USD MILLION)
TABLE 286. FRANCE NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY HOSPITALS AND CLINICS, 2025-2030 (USD MILLION)
TABLE 287. RUSSIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 288. RUSSIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 289. RUSSIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY ALLOGENEIC, 2018-2024 (USD MILLION)
TABLE 290. RUSSIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY ALLOGENEIC, 2025-2030 (USD MILLION)
TABLE 291. RUSSIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY AUTOLOGOUS, 2018-2024 (USD MILLION)
TABLE 292. RUSSIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY AUTOLOGOUS, 2025-2030 (USD MILLION)
TABLE 293. RUSSIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 294. RUSSIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 295. RUSSIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2018-2024 (USD MILLION)
TABLE 296. RUSSIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, 2025-2030 (USD MILLION)
TABLE 297. RUSSIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY SOLID TUMORS, 2018-2024 (USD MILLION)
TABLE 298. RUSSIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY SOLID TUMORS, 2025-2030 (USD MILLION)
TABLE 299. RUSSIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 300. RUSSIA NATURAL KILLER CEL

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Natural Killer Cell Therapeutics market report include:
  • Fate Therapeutics, Inc.
  • Nkarta Therapeutics, Inc.
  • Allogene Therapeutics, Inc.
  • Bristol-Myers Squibb Company
  • Gamida Cell Ltd.
  • Takeda Pharmaceutical Company Limited
  • Kyowa Kirin Co., Ltd.
  • Innate Pharma S.A.
  • Artiva Biotherapeutics, Inc.
  • Kiadis Pharma N.V.

Table Information

Report AttributeDetails
No. of Pages191
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 6.74 Billion
Forecasted Market Value ( USD ) by 2030 $ 11.72 Billion
Compound Annual Growth Rate11.7%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Natural Killer Cells Therapeutics - Global Strategic Business Report - Product Image

Natural Killer Cells Therapeutics - Global Strategic Business Report

  • Report
  • 365 Pages
  • Global
From
Natural Killer (NK) Cell Therapeutics Global Market Report 2025 - Product Image

Natural Killer (NK) Cell Therapeutics Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
IPSC Derived NK Cells- Pipeline Insight, 2025 - Product Image

IPSC Derived NK Cells- Pipeline Insight, 2025

  • Drug Pipelines
  • 60 Pages
  • Global
From
Brainstorm Cell Therapeutics Inc (BCLI:NAS): Financial Analysis, Benchmarks Against Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts - Product Image

Brainstorm Cell Therapeutics Inc (BCLI:NAS): Financial Analysis, Benchmarks Against Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts

  • Report
  • 111 Pages
  • Global
From
NK Cell Therapies - Pipeline Insight, 2025 - Product Image

NK Cell Therapies - Pipeline Insight, 2025

  • Clinical Trials
  • 120 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.